Dr. Ramdial is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-745-3458
Education & Training
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 2013 - 2016
- University of Miami Leonard M. Miller School of MedicineClass of 2013
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2026
- TN State Medical License 2023 - 2026
- TX State Medical License 2020 - 2026
- WA State Medical License 2023 - 2026
- AL State Medical License 2023 - 2025
- GA State Medical License 2023 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- Hematopoietic Stem Cell Transplantation in Patients With Myelofibrosis and Splanchnic Vein Thrombosis: A Case Series.Portia Smallbone, Mallika Sekhar, Samer A Srour, Jeremy L Ramdial, Crystal L Carmicheal Kusy
American Journal of Hematology. 2024-12-09 - High activity of the new myeloablative regimen of gemcitabine/clofarabine/busulfan for allogeneic transplant for aggressive lymphomas.Jeremy Ramdial, Ruitao Lin, Peter F Thall, Benigno C Valdez, Chitra Hosing
Bone Marrow Transplantation. 2024-12-01 - Impact of body mass index on outcomes of multiple myeloma patients undergoing upfront autologous stem cell transplant.Curtis Marcoux, Sarah Pasyar, Denái R Milton, Hina N Khan, Mark R Tanner
British Journal of Haematology. 2024-11-28
Abstracts/Posters
- The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)Jeremy Ramdial, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Somatic Mutations Improve Risk Classification By Cytogenetic Abnormalities in Patients with Myelodysplastic Syndrome after Hematopoietic Stem Cell TransplantationJeremy Ramdial, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: